Quality and GMP Compliance for Virtual Companies (Pharmaceutical and Biologics Industries)
Website https://www.complianceonline.com/fda-ema-inspection-gmp-gcp-qa-for-virtual-companies-seminar-trainin |
Edit Freely
Category
Deadline: November 29, 2020 | Date: December 10, 2020-December 11, 2020
Venue/Country: Virtual Seminar, U.S.A
Updated: 2020-11-29 22:04:02 (GMT+9)
Call For Papers - CFP
Today, many companies operate on an outsourcing model. This is very common for companies who are evolving from being mainly development-focused to a point where they are entering latter stages of Phase 2 or Phase 3 clinical trials, and plan to have a product ready for market approval in the coming months. Most such companies are small, and may not have deep expertise in QA and GMP compliance, relying on their partners to cover those areas. Companies who outsource the majority of operations through the use of Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs) and Contract Laboratories, however, remain responsible for the quality and compliance status of the products they send to the clinic or to the marketplace.Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.